CIK 0001071255
GDEN GOLDEN ENTERTAINMENT, INC.
Insider trading from SEC Form 4. Last filing Jun 17, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company
Signals
Open-market buys and sells at GOLDEN ENTERTAINMENT, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Blake L Sartini II EVP of Operations sell | $620k 23,979 shares | -14% | - | |
| 23Weak | Terrence Wright director sell | $518k 16,586 shares | -21% | - |
Congressional trades
1 trade in GDEN disclosed by members of Congress under the STOCK Act. All congressional trades.
- Susie LeeHouse · D-NV · last Apr 11, 20250 bought
1 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Susie Lee House · D-NV | Sale | GDEN Golden Entertainment, Inc. - Common Stock | $1,001 to $15k | Mar 14, 2025 / Apr 11, 2025 28 days after the trade | Clerk |
Transactions
The last 62 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2025 | Blake L Sartini Chairman and CEO | MOption exercise Common Stock | +440,000 | $5.34 | $2.3M | 440,000 | Jun 17, 2025 |
| Jun 17, 2025 | Blake L Sartini Chairman and CEO | FTax withholding Common Stock | -223,584 | $28.25 | $6.3M | 216,416 | Jun 17, 2025 |
| Jun 17, 2025 | Blake L Sartini Chairman and CEO | MOption exercise Stock Optionderivative | -440,000 | $0.00 | $0 | 0 | Jun 17, 2025 |
| May 23, 2025 | Andy H Chien director | AGrant or award Restricted Stock Unitsderivative | +5,657 | $0.00 | $0 | 5,657 | May 23, 2025 |
| May 23, 2025 | Ann Dozier director | MOption exercise Common Stock | +5,375 | - | - | 45,741 | May 23, 2025 |
| May 23, 2025 | Terrence Wright director | AGrant or award Restricted Stock Unitsderivative | +5,657 | $0.00 | $0 | 5,657 | May 23, 2025 |
| May 23, 2025 | Mark A Lipparelli director | AGrant or award Restricted Stock Unitsderivative | +5,657 | $0.00 | $0 | 5,657 | May 23, 2025 |
| May 23, 2025 | Ann Dozier director | AGrant or award Restricted Stock Unitsderivative | +5,657 | $0.00 | $0 | 5,657 | May 23, 2025 |
| May 23, 2025 | Ann Dozier director | MOption exercise Restricted Stock Unitsderivative | -5,375 | $0.00 | $0 | 0 | May 23, 2025 |
| Apr 2, 2025 | Blake L Sartini Chairman and CEO | GGift Common Stock | -46,178 | $0.00 | $0 | 0 | Apr 4, 2025 |
| Apr 2, 2025 | Blake L Sartini Chairman and CEO | AGrant or award Common Stockindirect: By Trust | +46,178 | $0.00 | $0 | 5,644,788 | Apr 4, 2025 |
| Mar 14, 2025 | Thomas Edwin Haas SVP of Accounting | MOption exercise Common Stock | +737 | - | - | 36,703 | Mar 14, 2025 |
| Mar 12, 2025 | Blake L Sartini II EVP of Operations | MOption exercise Common Stock | +25,000 | $5.34 | $134k | 166,460 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini Chairman and CEO | MOption exercise Common Stock | +11,177 | - | - | 11,177 | Mar 14, 2025 |
| Mar 14, 2025 | Charles Protell President and CFO | MOption exercise Common Stock | +6,428 | - | - | 530,397 | Mar 14, 2025 |
| Mar 12, 2025 | Blake L Sartini II EVP of Operations | FTax withholding Common Stock | -12,985 | $26.74 | $347k | 153,475 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini Chairman and CEO | MOption exercise Common Stock | +30,042 | - | - | 41,219 | Mar 14, 2025 |
| Mar 14, 2025 | Thomas Edwin Haas SVP of Accounting | MOption exercise Common Stock | +1,980 | - | - | 38,683 | Mar 14, 2025 |
| Mar 14, 2025 | Charles Protell President and CFO | MOption exercise Common Stock | +17,276 | - | - | 547,673 | Mar 14, 2025 |
| Mar 14, 2025 | Thomas Edwin Haas SVP of Accounting | MOption exercise Common Stock | +1,004 | - | - | 39,687 | Mar 14, 2025 |
| Mar 14, 2025 | Charles Protell President and CFO | MOption exercise Common Stock | +8,756 | - | - | 556,429 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini Chairman and CEO | MOption exercise Common Stock | +15,225 | - | - | 56,444 | Mar 14, 2025 |
| Mar 13, 2025 | Blake L Sartini II EVP of Operations | MOption exercise Common Stock | +25,000 | $5.34 | $134k | 178,475 | Mar 14, 2025 |
| Mar 14, 2025 | Charles Protell President and CFO | MOption exercise Common Stock | +11,780 | - | - | 568,209 | Mar 14, 2025 |
| Mar 14, 2025 | Thomas Edwin Haas SVP of Accounting | MOption exercise Common Stock | +1,500 | - | - | 41,187 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini Chairman and CEO | MOption exercise Common Stock | +19,696 | - | - | 76,140 | Mar 14, 2025 |
| Mar 13, 2025 | Blake L Sartini II EVP of Operations | FTax withholding Common Stock | -12,968 | $25.62 | $332k | 165,507 | Mar 14, 2025 |
| Mar 14, 2025 | Charles Protell President and CFO | FTax withholding Common Stock | -17,430 | $26.17 | $456k | 550,779 | Mar 14, 2025 |
| Mar 14, 2025 | Thomas Edwin Haas SVP of Accounting | FTax withholding Common Stock | -1,506 | $26.17 | $39k | 39,681 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini Chairman and CEO | FTax withholding Common Stock | -29,962 | $26.17 | $784k | 46,178 | Mar 14, 2025 |
| Mar 13, 2025 | Blake L Sartini II EVP of Operations | SOpen-market sale Common Stock | -23,979 | $25.87 | $620k | 141,528 | Mar 14, 2025 |
| Mar 14, 2025 | Charles Protell President and CFO | AGrant or award Restricted Stock Unitsderivative | +41,747 | $0.00 | $0 | 41,747 | Mar 14, 2025 |
| Mar 14, 2025 | Thomas Edwin Haas SVP of Accounting | AGrant or award Restricted Stock Unitsderivative | +2,659 | $0.00 | $0 | 2,659 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini II EVP of Operations | MOption exercise Common Stock | +2,947 | - | - | 144,475 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini II EVP of Operations | MOption exercise Common Stock | +7,922 | - | - | 152,397 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini Chairman and CEO | AGrant or award Restricted Stock Unitsderivative | +69,799 | $0.00 | $0 | 69,799 | Mar 14, 2025 |
| Mar 14, 2025 | Charles Protell President and CFO | MOption exercise Restricted Stock Unitsderivative | -6,428 | $0.00 | $0 | 0 | Mar 14, 2025 |
| Mar 14, 2025 | Thomas Edwin Haas SVP of Accounting | MOption exercise Restricted Stock Unitsderivative | -737 | $0.00 | $0 | 0 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini II EVP of Operations | MOption exercise Common Stock | +4,238 | - | - | 156,635 | Mar 14, 2025 |
| Mar 14, 2025 | Thomas Edwin Haas SVP of Accounting | MOption exercise Restricted Stock Unitsderivative | -1,980 | $0.00 | $0 | 0 | Mar 14, 2025 |
| Mar 14, 2025 | Charles Protell President and CFO | MOption exercise Restricted Stock Unitsderivative | -17,276 | $0.00 | $0 | 0 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini Chairman and CEO | MOption exercise Restricted Stock Unitsderivative | -11,177 | $0.00 | $0 | 0 | Mar 14, 2025 |
| Mar 14, 2025 | Thomas Edwin Haas SVP of Accounting | MOption exercise Restricted Stock Unitsderivative | -1,004 | $0.00 | $0 | 1,005 | Mar 14, 2025 |
| Mar 14, 2025 | Charles Protell President and CFO | MOption exercise Restricted Stock Unitsderivative | -8,756 | $0.00 | $0 | 8,758 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini Chairman and CEO | MOption exercise Restricted Stock Unitsderivative | -30,042 | $0.00 | $0 | 0 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini II EVP of Operations | MOption exercise Common Stock | +5,940 | - | - | 162,575 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini II EVP of Operations | FTax withholding Common Stock | -8,405 | $26.17 | $220k | 154,170 | Mar 14, 2025 |
| Mar 14, 2025 | Thomas Edwin Haas SVP of Accounting | MOption exercise Restricted Stock Unitsderivative | -1,500 | $0.00 | $0 | 3,002 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini Chairman and CEO | MOption exercise Restricted Stock Unitsderivative | -15,225 | $0.00 | $0 | 15,229 | Mar 14, 2025 |
| Mar 14, 2025 | Charles Protell President and CFO | MOption exercise Restricted Stock Unitsderivative | -11,780 | $0.00 | $0 | 23,560 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini Chairman and CEO | MOption exercise Restricted Stock Unitsderivative | -19,696 | $0.00 | $0 | 39,392 | Mar 14, 2025 |
| Mar 12, 2025 | Blake L Sartini II EVP of Operations | MOption exercise Stock Optionderivative | -25,000 | $0.00 | $0 | 25,000 | Mar 14, 2025 |
| Mar 13, 2025 | Blake L Sartini II EVP of Operations | MOption exercise Stock Optionderivative | -25,000 | $0.00 | $0 | 0 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini II EVP of Operations | AGrant or award Restricted Stock Unitsderivative | +24,374 | $0.00 | $0 | 24,374 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini II EVP of Operations | MOption exercise Restricted Stock Unitsderivative | -2,947 | $0.00 | $0 | 0 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini II EVP of Operations | MOption exercise Restricted Stock Unitsderivative | -7,922 | $0.00 | $0 | 0 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini II EVP of Operations | MOption exercise Restricted Stock Unitsderivative | -4,238 | $0.00 | $0 | 4,240 | Mar 14, 2025 |
| Mar 14, 2025 | Blake L Sartini II EVP of Operations | MOption exercise Restricted Stock Unitsderivative | -5,940 | $0.00 | $0 | 11,880 | Mar 14, 2025 |
| Dec 20, 2024 | Terrence Wright director | MOption exercise Common Stock | +20,000 | $5.34 | $107k | 81,616 | Dec 20, 2024 |
| Dec 20, 2024 | Terrence Wright director | FTax withholding Common Stock | -3,414 | $31.26 | $107k | 78,202 | Dec 20, 2024 |
| Dec 20, 2024 | Terrence Wright director | SOpen-market sale Common Stock | -16,586 | $31.26 | $518k | 61,616 | Dec 20, 2024 |
| Dec 20, 2024 | Terrence Wright director | MOption exercise Stock Optionderivative | -20,000 | $0.00 | $0 | 0 | Dec 20, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Andy H Chiendirector
- Ann Dozierdirector
- Thomas Edwin HaasSVP of Accounting
- Mark A Lipparellidirector
- Charles ProtellPresident and CFO
- Blake L SartiniChairman and CEO
- Blake L Sartini IIEVP of Operations
- Terrence Wrightdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.